Caligan Partners’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-184,826
| Closed | -$1.06M | – | 17 |
|
|
2024
Q4 | $1.06M | Sell |
184,826
-137,627
| -43% | -$791K | 0.27% | 14 |
|
|
2024
Q3 | $3.34M | Sell |
322,453
-720,436
| -69% | -$7.46M | 1.06% | 11 |
|
|
2024
Q2 | $13.5M | Buy |
1,042,889
+184,819
| +22% | +$2.4M | 3.16% | 9 |
|
|
2024
Q1 | $15M | Buy |
+858,070
| New | +$15M | 3.96% | 7 |
|